Deferred Tax Assets, Net of Valuation Allowance of KalVista Pharmaceuticals, Inc. from 31 Dec 2014 to 30 Apr 2025

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: KalVista Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2014 to 30 Apr 2025.
KalVista Pharmaceuticals, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 30 Apr 2025 was $1,120,000, a 22% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

KalVista Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$1,120,000	-$310,000	-22%	30 Apr 2025	10-K	10 Jul 2025	2025	FY
Q1 2024	$1,430,000	-$332,000	-19%	30 Apr 2024	10-K	10 Jul 2025	2025	FY
Q1 2023	$1,762,000	+$185,000	+12%	30 Apr 2023	10-K	11 Jul 2024	2024	FY
Q1 2022	$1,577,000	+$399,000	+34%	30 Apr 2022	10-K	10 Jul 2023	2023	FY
Q1 2021	$1,178,000			30 Apr 2021	10-K	07 Jul 2022	2022	FY
Q4 2015	$63,000	-$1,121,000	-95%	31 Dec 2015	10-K	30 Mar 2016	2015	FY
Q4 2014	$1,184,000			31 Dec 2014	10-K	30 Mar 2016	2015	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.